|
|
|
Insider
Information: |
Sullivan Louis |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
178,473 |
|
Indirect Shares
|
20,185 |
|
|
Direct
Value |
$10,198,480 |
|
|
Indirect Value
|
$2,011,032 |
|
|
Total
Shares |
198,658 |
|
|
Total
Value |
$12,209,511 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
-8.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
Premium* |
|
3M Co |
MMM |
Director |
2006-05-09 |
1,722 |
2006-05-09 |
20,185 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2005-04-29 |
8,399 |
2004-04-23 |
0 |
Premium* |
|
Equifax Inc |
EFX |
Director |
2004-05-05 |
6,033 |
2004-05-05 |
0 |
Premium* |
|
Henry Schein Inc |
HSIC |
Director |
2016-03-04 |
14,096 |
2005-03-18 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-05-03 |
13,060 |
2007-12-11 |
0 |
Premium* |
|
Emergent Biosolutions Inc. |
EBS |
Director |
2023-05-25 |
87,265 |
2010-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MMM |
3M Co |
Director |
|
2003-08-11 |
4 |
A |
$141.90 |
$36,894 |
I/I |
260 |
7,684 |
|
- |
|
MMM |
3M Co |
Director |
|
2003-09-12 |
4 |
A |
$142.14 |
$4,833 |
I/I |
34 |
7,718 |
|
- |
|
MMM |
3M Co |
Director |
|
2003-11-10 |
4 |
A |
$78.84 |
$6,859 |
I/I |
87 |
15,523 |
|
- |
|
MMM |
3M Co |
Director |
|
2004-02-09 |
4 |
A |
$79.39 |
$6,907 |
I/I |
87 |
15,674 |
|
- |
|
MMM |
3M Co |
Director |
|
2004-05-11 |
4 |
A |
$84.15 |
$101,906 |
I/I |
1,211 |
16,954 |
|
- |
|
MMM |
3M Co |
Director |
|
2004-08-10 |
4 |
A |
$79.45 |
$6,912 |
I/I |
87 |
17,108 |
|
- |
|
MMM |
3M Co |
Director |
|
2004-11-08 |
4 |
A |
$81.38 |
$6,836 |
I/I |
84 |
17,271 |
|
- |
|
MMM |
3M Co |
Director |
|
2005-02-14 |
4 |
A |
$82.07 |
$6,894 |
I/I |
84 |
17,431 |
|
- |
|
MMM |
3M Co |
Director |
|
2005-05-10 |
4 |
A |
$85.69 |
$101,885 |
I/I |
1,189 |
18,704 |
|
- |
|
MMM |
3M Co |
Director |
|
2005-08-08 |
4 |
A |
$72.30 |
$9,399 |
I/I |
130 |
18,931 |
|
- |
|
MMM |
3M Co |
Director |
|
2005-11-14 |
4 |
A |
$73.36 |
$9,390 |
I/I |
128 |
19,168 |
|
- |
|
MMM |
3M Co |
Director |
|
2006-02-13 |
4 |
A |
$77.50 |
$18,755 |
I/I |
242 |
19,514 |
|
- |
|
MMM |
3M Co |
Director |
|
2006-05-09 |
4 |
A |
$75.69 |
$41,630 |
I/I |
550 |
20,185 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2003-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
186 |
14,413 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2003-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
113 |
14,526 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2003-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
124 |
14,650 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
87 |
14,737 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
422 |
15,159 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
87 |
15,246 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
152 |
15,398 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2004-10-22 |
4 |
OE |
$2.85 |
$35,625 |
D/D |
12,500 |
27,898 |
|
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2011-01-13 |
4 |
B |
$1.72 |
$17,200 |
D/D |
10,000 |
37,898 |
2.39 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2011-08-15 |
4 |
B |
$2.67 |
$26,700 |
D/D |
10,000 |
47,898 |
2.39 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2004-04-23 |
4 |
D |
$24.80 |
$55,329 |
D/D |
(2,231) |
6,688 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2004-04-23 |
4 |
OE |
$13.15 |
$55,322 |
D/D |
4,207 |
8,919 |
|
- |
|
169 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|